Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Idenix says Novartis
not to license Hepatitis C
drug 4:44 PM 10/29/2009
Reuters
Idenix
Pharmaceuticals Inc said Novartis Pharma has decided not to exercise its option to license Idenix's hepatitis C
drug IDX184. Idenix will seek a new partner.
...
Statin
drugs may lower deaths from flu - study 12:19 PM 10/29/2009
Reuters
Patients taking cholesterol-lowering statin drugs were almost 50 percent
less likely to die from influenza infection.
...
Transcept
Pharma sleep drug denied approval 6:40 AM 10/29/2009
Reuters
Transcept Pharmaceuticals said the US FDA did not approve its experimental sleep
disorder drug Intermezzo citing safety issues. The FDA expressed concerns regarding the possibility of dosing
errors and effects in the middle of the night.
...
Roche:
New Diabetes Drug Works Better Than Byetta - Study 5:03 AM 10/29/2009
Wall Street Journal
Roche Holding said its experimental diabetes drug taspoglutide
worked better than a rival drug sold by Eli Lilly & Co in lowering blood sugar.
...
Sanofi,
Micromet seal early-stage cancer drug deal 4:43 AM 10/29/2009
Reuters
Sanofi-Aventis and US-based Micromet signed a global deal to develop an early-stage
cancer treatment. Sanofi will further develop Micromet's antibody BiTE which activates certain cells in the body
to target and destroy solid cancer cells.
...
Stryker
Biotech faces indictment 2:03 AM 10/29/2009
Boston Globe
The indictment accused Stryker Biotech of promoting the use of OP-1 Implant and
OP-1 Putty devices made for spinal and long bone surgeries for applications that had not been approved by the US
FDA.
...
Novartis
says EU approves inflammatory disease drug 1:00 PM 10/28/2009
Reuters
The European Union approved Novartis' drug Ilaris to treat children and
adults with a rare but potentially fatal inflammatory disease. The EU decision follows approvals in the US and
Switzerland.
...
Vertex
hep C drug helps tough to treat patients 6:20 AM 10/28/2009
Reuters
Vertex Pharmaceuticals Inc's hepatitis C drug telaprevir killed virus in a
significant number of patients who had failed to respond to standard treatments or relapsed.
...
AstraZeneca
Pulls Cancer Drug Applications 5:41 AM 10/28/2009
Wall Street Journal
AstraZeneca has pulled US and European regulatory applications for its
cancer drug Zactima after its effectiveness was called into question by reviewers.
...
Antipsychotic
Drugs in Kids Linked to Weight Gain, Study Finds 3:45 PM 10/27/2009
Bloomberg
Children and teens who took antipsychotic medicines gained weight and
developed increased blood-fat levels. Subjects taking the drugs for the first time gained up to 18.7 pounds
after about a month of treatment.
...
Arena:
2nd weight loss trial shows cardiac benefit 9:14 AM 10/27/2009
Reuters
Arena Pharmaceuticals said detailed results from a second pivotal trial of its
experimental obesity drug lorcaserin show that it improves cardiovascular risk factors.
...
Icagen
asthma drug senicapoc trial fails 8:44 AM 10/27/2009
Forbes
Icagen Inc said its experimental asthma drug senicapoc failed the main goals of a
midstage study. It will not develop the drug further.
...
Obama
agenda: Vaccine blame game 8:14 AM 10/27/2009
msnbc.com
Obama promised 120 million doses by mid-October spending $2 billion to inoculate
every American. Less than 17 million doses available so far. The election is over; it's time to under-promise
and deliver.
...
Astellas, Medivation in
prostate-cancer drug pact 7:17 AM 10/27/2009
Reuters
Astellas Pharma Inc has agreed to license experimental prostate cancer drug MDV3100
from US biotech Medivation Inc with an up-front payment of $110 million.
...
Glaxo, Genmab win U.S. approval
for leukemia drug 5:02 AM 10/27/2009
Reuters
GlaxoSmithKline and Genmab have won US approval for leukemia drug Arzerra for patients
with chronic lymphocytic leukemia (CLL) who do not respond to Genzyme's Campath or chemotherapy drug
fludarabine.
...
<- Day Earlier | Today's News
|
